本页面由Tiger Trade Technology Pte. Ltd.提供服务

Redhill Biopharma Ltd

0.8100
0.0000
成交量:7,528.00
成交额:6,098.09
市值:412.48万
市盈率:-0.13
高:0.8100
开:0.8100
低:0.8100
收:0.8100
52周最高:3.31
52周最低:0.7101
股本:509.23万
流通股本:332.99万
量比:0.86
换手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):-6.0249
每股收益(LYR):-6.7096
净资产收益率:-1708.61%
总资产收益率:-25.32%
市净率:-0.93
市盈率(LYR):-0.12

数据加载中...

2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

SEC问询函

[Cover]Correspondence
2019/07/24

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/15

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]